Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

Nubia Muñoz; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricía J Garcia; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Warner K Huh; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Heather L Sings; Margaret K James; Teresa M Hesley; Eliav Barr; Richard M Haupt

doi:http://dx.doi.org/10.1093/jnci/djp534

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

Nubia Muñoz, Susanne K Kjaer, Kristján Sigurdsson, Ole-Erik Iversen, Mauricio Hernandez-Avila, Cosette M Wheeler, Gonzalo Perez, Darron R Brown, Laura A Koutsky, Eng Hseon Tay, Patricía J Garcia, Kevin A Ault, Suzanne M Garland, Sepp Leodolter, Sven-Eric Olsson, Grace W K Tang, Daron G Ferris, Jorma Paavonen, Marc Steben, F Xavier BoschJoakim Dillner, Warner K Huh, Elmar A Joura, Robert J Kurman, Slawomir Majewski, Evan R Myers, Luisa L Villa, Frank J Taddeo, Christine Roberts, Amha Tadesse, Janine T Bryan, Lisa C Lupinacci, Katherine E D Giacoletti, Heather L Sings, Margaret K James, Teresa M Hesley, Eliav Barr, Richard M Haupt

Research output: Contribution to journal › Journal article › Research › peer-review

485 Citations (Scopus)

Abstract

The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).

Original language	English
Journal	National Cancer Institute. Journal (Online)
Volume	102
Issue number	5
Pages (from-to)	325-39
Number of pages	15
ISSN	1460-2105
DOIs	https://doi.org/10.1093/jnci/djp534
Publication status	Published - 3 Mar 2010

Access to Document

http://dx.doi.org/10.1093/jnci/djp534

Cite this

Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., Garcia, P. J., Ault, K. A., Garland, S. M., Leodolter, S., Olsson, S-E., Tang, G. W. K., Ferris, D. G., Paavonen, J., Steben, M., ... Haupt, R. M. (2010). Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. National Cancer Institute. Journal (Online), 102(5), 325-39. https://doi.org/10.1093/jnci/djp534

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. / Muñoz, Nubia; Kjaer, Susanne K; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Wheeler, Cosette M; Perez, Gonzalo; Brown, Darron R; Koutsky, Laura A; Tay, Eng Hseon; Garcia, Patricía J; Ault, Kevin A; Garland, Suzanne M; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W K; Ferris, Daron G; Paavonen, Jorma; Steben, Marc; Bosch, F Xavier; Dillner, Joakim; Huh, Warner K; Joura, Elmar A; Kurman, Robert J; Majewski, Slawomir; Myers, Evan R; Villa, Luisa L; Taddeo, Frank J; Roberts, Christine; Tadesse, Amha; Bryan, Janine T; Lupinacci, Lisa C; Giacoletti, Katherine E D; Sings, Heather L; James, Margaret K; Hesley, Teresa M; Barr, Eliav; Haupt, Richard M.

In: National Cancer Institute. Journal (Online), Vol. 102, No. 5, 03.03.2010, p. 325-39.

Research output: Contribution to journal › Journal article › Research › peer-review

Muñoz, N, Kjaer, SK, Sigurdsson, K, Iversen, O-E, Hernandez-Avila, M, Wheeler, CM, Perez, G, Brown, DR, Koutsky, LA, Tay, EH, Garcia, PJ, Ault, KA, Garland, SM, Leodolter, S, Olsson, S-E, Tang, GWK, Ferris, DG, Paavonen, J, Steben, M, Bosch, FX, Dillner, J, Huh, WK, Joura, EA, Kurman, RJ, Majewski, S, Myers, ER, Villa, LL, Taddeo, FJ, Roberts, C, Tadesse, A, Bryan, JT, Lupinacci, LC, Giacoletti, KED, Sings, HL, James, MK, Hesley, TM, Barr, E & Haupt, RM 2010, 'Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women', National Cancer Institute. Journal (Online), vol. 102, no. 5, pp. 325-39. https://doi.org/10.1093/jnci/djp534

Muñoz, Nubia ; Kjaer, Susanne K ; Sigurdsson, Kristján ; Iversen, Ole-Erik ; Hernandez-Avila, Mauricio ; Wheeler, Cosette M ; Perez, Gonzalo ; Brown, Darron R ; Koutsky, Laura A ; Tay, Eng Hseon ; Garcia, Patricía J ; Ault, Kevin A ; Garland, Suzanne M ; Leodolter, Sepp ; Olsson, Sven-Eric ; Tang, Grace W K ; Ferris, Daron G ; Paavonen, Jorma ; Steben, Marc ; Bosch, F Xavier ; Dillner, Joakim ; Huh, Warner K ; Joura, Elmar A ; Kurman, Robert J ; Majewski, Slawomir ; Myers, Evan R ; Villa, Luisa L ; Taddeo, Frank J ; Roberts, Christine ; Tadesse, Amha ; Bryan, Janine T ; Lupinacci, Lisa C ; Giacoletti, Katherine E D ; Sings, Heather L ; James, Margaret K ; Hesley, Teresa M ; Barr, Eliav ; Haupt, Richard M. / Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. In: National Cancer Institute. Journal (Online). 2010 ; Vol. 102, No. 5. pp. 325-39.

@article{3450e6d1877940838ef383649d59157f,

title = "Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women",

abstract = "The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were {"}negative to 14 HPV types{"} and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).",

author = "Nubia Mu{\~n}oz and Kjaer, {Susanne K} and Kristj{\'a}n Sigurdsson and Ole-Erik Iversen and Mauricio Hernandez-Avila and Wheeler, {Cosette M} and Gonzalo Perez and Brown, {Darron R} and Koutsky, {Laura A} and Tay, {Eng Hseon} and Garcia, {Patric{\'i}a J} and Ault, {Kevin A} and Garland, {Suzanne M} and Sepp Leodolter and Sven-Eric Olsson and Tang, {Grace W K} and Ferris, {Daron G} and Jorma Paavonen and Marc Steben and Bosch, {F Xavier} and Joakim Dillner and Huh, {Warner K} and Joura, {Elmar A} and Kurman, {Robert J} and Slawomir Majewski and Myers, {Evan R} and Villa, {Luisa L} and Taddeo, {Frank J} and Christine Roberts and Amha Tadesse and Bryan, {Janine T} and Lupinacci, {Lisa C} and Giacoletti, {Katherine E D} and Sings, {Heather L} and James, {Margaret K} and Hesley, {Teresa M} and Eliav Barr and Haupt, {Richard M}",

year = "2010",

month = mar,

day = "3",

doi = "http://dx.doi.org/10.1093/jnci/djp534",

language = "English",

volume = "102",

pages = "325--39",

journal = "National Cancer Institute. Journal (Online)",

issn = "1460-2105",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

AU - Muñoz, Nubia

AU - Kjaer, Susanne K

AU - Sigurdsson, Kristján

AU - Iversen, Ole-Erik

AU - Hernandez-Avila, Mauricio

AU - Wheeler, Cosette M

AU - Perez, Gonzalo

AU - Brown, Darron R

AU - Koutsky, Laura A

AU - Tay, Eng Hseon

AU - Garcia, Patricía J

AU - Ault, Kevin A

AU - Garland, Suzanne M

AU - Leodolter, Sepp

AU - Olsson, Sven-Eric

AU - Tang, Grace W K

AU - Ferris, Daron G

AU - Paavonen, Jorma

AU - Steben, Marc

AU - Bosch, F Xavier

AU - Dillner, Joakim

AU - Huh, Warner K

AU - Joura, Elmar A

AU - Kurman, Robert J

AU - Majewski, Slawomir

AU - Myers, Evan R

AU - Villa, Luisa L

AU - Taddeo, Frank J

AU - Roberts, Christine

AU - Tadesse, Amha

AU - Bryan, Janine T

AU - Lupinacci, Lisa C

AU - Giacoletti, Katherine E D

AU - Sings, Heather L

AU - James, Margaret K

AU - Hesley, Teresa M

AU - Barr, Eliav

AU - Haupt, Richard M

PY - 2010/3/3

Y1 - 2010/3/3

N2 - The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).

AB - The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).

U2 - http://dx.doi.org/10.1093/jnci/djp534

DO - http://dx.doi.org/10.1093/jnci/djp534

M3 - Journal article

VL - 102

SP - 325

EP - 339

JO - National Cancer Institute. Journal (Online)

JF - National Cancer Institute. Journal (Online)

SN - 1460-2105

IS - 5

ER -